These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36009464)

  • 1. Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis.
    Kaliszewski K; Diakowska D; Rzeszutko M; Nowak Ł; Wojtczak B; Sutkowski K; Ludwig M; Ludwig B; Mikuła A; Greniuk M; Tokarczyk U; Rudnicki J
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
    Rosario PW
    Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.
    Topaloglu O; Baser H; Cuhaci FN; Sungu N; Yalcin A; Ersoy R; Cakir B
    Endocrine; 2016 Oct; 54(1):156-168. PubMed ID: 27172917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
    Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
    Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
    Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid cytology in Pakistan: An institutional audit of the atypia of undetermined significance/follicular lesion of undetermined significance category.
    Fatima S; Qureshi R; Imran S; Idrees R; Ahmad Z; Kayani N; Ahmed A
    Cytopathology; 2021 Mar; 32(2):205-210. PubMed ID: 33098589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHICH FACTORS ARE ASSOCIATED WITH MALIGNANCY IN THYROID NODULES CLASSIFIED AS BETHESDA CATEGORY 3 (AUS/FLUS) AND HOW DO THEY INFLUENCE THE PATIENT'S MANAGEMENT?
    Kaya C; Bozkurt E; Türkyılmaz Mut D; Mihmanli M; Uludağ M
    Acta Endocrinol (Buchar); 2019; 15(4):491-496. PubMed ID: 32377247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
    Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
    Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancy Rates of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cases: A Tertiary Center Study.
    Erdogan-Durmus S; Balta H; Demirtas R; Kurt A
    Acta Endocrinol (Buchar); 2021; 17(1):77-82. PubMed ID: 34539913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China.
    Zhao H; Guo H; Zhao L; Cao J; Sun Y; Wang C; Zhang Z
    Cancer Cytopathol; 2021 Aug; 129(8):642-648. PubMed ID: 34139103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
    Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
    Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ
    Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
    Hong HS; Lee JY
    AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology.
    Park VY; Kim EK; Kwak JY; Yoon JH; Moon HJ
    Eur Radiol; 2015 Sep; 25(9):2601-7. PubMed ID: 25740802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
    Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of repeat fine-needle aspiration in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance: A single center experience.
    Marin F; Murillo R; Diego C; Jodar E; Acevedo A
    Diagn Cytopathol; 2021 Mar; 49(3):412-417. PubMed ID: 33252841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience.
    Almahari SA; Harb Z; Alshaikh S
    Cytojournal; 2019; 16():18. PubMed ID: 31576199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypia and Follicular Lesions of Undetermined Significance in Subsequent Biopsy Result: What Clinicians Need to Know.
    Kaliszewski K; Diakowska D; Rzeszutko M; Nowak Ł; Tokarczyk U; Rudnicki J
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.